Björn Ursing: Physicians new role in AI driven healthcare

”AI could be the key we need for tomorrow’s healthcare, but it is not a stand-alone tool”, writes Björn Ursing in a column about how the role for physicians cha...

Galderma

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Eva Arlander rekryteras av Index Pharmaceuticals

Läkemedelsutvecklaren Index Pharmaceuticals har anställt Eva Arlander som Chief Development Officer och medlem i bolagets nya ledningsgrupp. Samtidigt genomförs...

Fem saker du måste veta om AI 2023

Är ditt jobb hotat av maskininlärning? Varför är det viktigt att hänga med i utvecklingen inom artificiell intelligens? Här får du svar på vad du behöver veta om AI just nu.

Automated opening and closing of sample vials

From technical requirements to a suitable solution

Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”

For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...

Stayble får europeiskt patent för engångsbehandling mot diskbråck

Stayble Therapeutics är på väg att beviljas ett europeiskt patent för sin behandling av diskbråck.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”

“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimen...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Microscope or Measuring Machine? Both!

Watch our demo recording with features, software and best-practices.

The International Vaccine Institute’s office in Sweden is expanding

The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Kriget i Ukraina ger bränsle åt totalt resistenta bakterier

Krigshärjade Ukraina lider inte bara av fientliga attacker från en utländsk angripare, utan också från hotet från en totalt resistent och smittsam bakterie.

Rising interest in CRISPR treatments

Treatments using CRISPR technology are emerging as one of the hottest medical trends in the United States – and the FDA is doing its best to promote the development.

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...

Bioarctic fälls för vd-uttalanden till journalist – efter anmälan från konkurrent

I ett vägledande utslag fälls alzheimerbolaget Bioarctic för uttalanden som bolagets vd gjorde till en ekonomijournalist i somras.

Jätteaffär på gång inom konsumenthälsa – Sanofi i förhandlingar

Franska Sanofi kan vara på väg att släppa greppet om sin division inom konsumenthälsa, Opella, i vad som kan bli årets största affär inom den europeiska hälsobranschen.

New diagnostic test soon ready for the market

Advancing 3D Culture Imaging: Insights from Academia, Biotech, and Pharma

Webinar | March 13, 2024, 12 PM EST.